GLYX-13, a NMDA Receptor Glycine-Site Functional Partial Agonist, Induces Antidepressant-Like Effects Without Ketamine-Like Side Effects

Recent human clinical studies with the NMDA receptor (NMDAR) antagonist ketamine have revealed profound and long-lasting antidepressant effects with rapid onset in several clinical trials, but antidepressant effects were preceded by dissociative side effects. Here we show that GLYX-13, a novel NMDAR...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Burgdorf, Jeffrey, Zhang, Xiao-lei, Nicholson, Katherine L, Balster, Robert L, David Leander, J, Stanton, Patric K, Gross, Amanda L, Kroes, Roger A, Moskal, Joseph R
Format: Artigo
Langue:Inglês
Publié: Nature Publishing Group 2013
Sujets:
Original Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3671991/
https://ncbi.nlm.nih.gov/pubmed/23303054
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/npp.2012.246
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires